Tianlong at SCO Medical Congress in Kyrgyzstan

The International Medical Congress of the Countries of the Cooperation Organization of Shanghai recently took place in Bishkek, Kyrgyzstan, focusing on “Innovations and technologies in the development of cardiology and non-communicable diseases in the countries of the Shanghai Cooperation Organization”. The event saw participation from prominent figures like Alymkady Beishenaliev, Minister of Health of the Kyrgyz Republic, and Janesh Kane, Deputy Secretary General of the SCO, along with 400 world-renowned medical professionals, academics, and scientists.

At the congress, Tianlong Science and Technology Company showcased its latest achievements in personalized medicine, contributing to discussions on the future of healthcare. Professor Kou Huijuan from the Department of Cardiology of the Second Affiliated Hospital of Xi’an Jiaotong University presented on precise treatment and the current progress of hypertension diagnosis and treatment in China, highlighting Tianlong’s personalized hypertension medication solution. This solution can identify genetic mutations in hypertension medications, guiding the selection of appropriate treatment for each patient, based on genetic differences.

Moreover, at an international conference on “Current Issues in Laboratory Medicine” in Kyrgyzstan, Jessica Wu from Tianlong discussed the company’s reagent kit LigSeq, emphasizing the significance of personalized medication solutions. These solutions detect genes relevant to drug effectiveness in treating various diseases, offering valuable insights for clinical treatment. Tianlong’s personalized medicine solutions cover a wide range of diseases and provide rapid and accurate detection results, making them highly user-friendly for medical professionals.

Tianlong’s active participation in medical conferences promotes international collaboration and knowledge sharing in the field of healthcare. The company remains committed to scientific research, innovation, and technological advancement to drive progress in medicine and healthcare on a global scale.

Tianlong, established in 1997, is an innovative high-tech company specializing in genetic detection and molecular diagnostic products in China. With a focus on providing cutting-edge PCR laboratory solutions, Tianlong aims to support professionals worldwide in advancing healthcare practices.

For more information about Tianlong and its groundbreaking products, please visit the official website and explore the company’s updates on LinkedIn, Facebook, and Twitter. Stay tuned for the latest developments in genetic detection and personalized medicine from Tianlong.

Photo: Professor Kou Huijuan presenting at the International Medical Congress of SCO Countries. (Image credit: PR Newswire)

Source link



Leave a Reply

Your email address will not be published. Required fields are marked *

Most Viewed

Featured Franchise Opportunity

Happy Cat Hotel & Spa

Pet Franchises

$250ˌ000 - $500ˌ000

Clean Nature Group

Business Services Franchises, Cleaning Franchises, Low Cost Franchises, Manufacturing & Industrial Franchises

$100ˌ000 - $250ˌ000